EUVIMEDEUVIMED entdecken
VergleichsstudieKohortenstudieOpen Access · CC BY 4.0

Comparative safety and effectiveness of oral anticoagulants in key subgroups of patients with non-valvular atrial fibrillation and at high risk of gastrointestinal bleeding: A cohort study based on the French National Health Data System (SNDS)

Gregory Y H Lip iD, Robert Benamouzig, Anne-Céline Martin, Giancarlo Pesce iD, Gaelle Gusto, Nadia Quignot iD, Artak Khachatryan, Feng Dai, Fouad Sedjelmaci, Jose Chaves iD, Rupesh Subash, Ruth Mokgokong iD

PLOS ONE · 22.01.2025 · 20 (1) · e0317895

DOI: 10.1371/journal.pone.0317895 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift PLOS ONE, online erschienen am 22.01.2025. Verfasst von Gregory Y H Lip und 11 weiteren Autor:innen. Beteiligte Einrichtung: Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverp…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Gastrointestinal Hemorrhage, Anticoagulants. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Risk factors and comorbidities can complicate management of non-valvular atrial fibrillation. We describe and compare real-world safety and effectiveness of direct oral anticoagulants (DOACs; apixaban, rivaroxaban, dabigatran) and vitamin K antagonists (VKAs) in subgroups of patients with non-valvular atrial fibrillation at high risk for gastrointestinal (GI) bleeding, utilizing data from a national quasi-exhaustive French database.

Methods

Anticoagulant-naïve adults with non-valvular atrial fibrillation with ≥1 gastrointestinal bleeding risk factor, initiating anticoagulant treatment January 2016–December 2019, and covered by the French national health data system were eligible. The following subgroups were evaluated: patients age ≥75 years, receiving concomitant medications, HAS-BLED score ≥3, and chronic kidney disease stage 3–4. Outcomes included major bleeding and stroke/systemic embolism. Patient characteristics were balanced using propensity score matching.

Results

A total of 314,184 patients were identified; characteristics were similar for propensity score-matched subgroups in VKA/DOAC and DOAC/DOAC comparisons. DOACs showed lower risk of major bleeding versus VKAs in all subgroups evaluated ( p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationGastrointestinal HemorrhageAnticoagulantsHumansAgedMaleFemaleFranceAged, 80 and overAdministration, OralRivaroxabanPyrazolesDabigatranMiddle AgedPyridonesStrokeRisk FactorsCohort StudiesVitamin KDatabases, Factual

Substanzen

AnticoagulantsRivaroxabanapixabanPyrazolesDabigatranPyridonesVitamin K

Autor:innen und Institutionen

  • Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom.
  • Danish Center for Health Services Research, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
  • Hôpital Avicenne, Bobigny, France.
  • European Hospital Georges Pompidou, Paris, France.
  • INSERM UMRS_1140, University of Paris, Paris, France.
  • Certara Italy, Milan, Italy.

ORCID-Profile: Gregory Y H Lip, Giancarlo Pesce, Nadia Quignot, Jose Chaves, Ruth Mokgokong

Zitieren

APA

Lip, G. Y. H., Benamouzig, R., Martin, A. C., Pesce, G., Gusto, G., Quignot, N., Khachatryan, A., Dai, F., Sedjelmaci, F., Chaves, J., Subash, R., & Mokgokong, R. (2025). Comparative safety and effectiveness of oral anticoagulants in key subgroups of patients with non-valvular atrial fibrillation and at high risk of gastrointestinal bleeding: A cohort study based on the French National Health Data System (SNDS). PLOS ONE, 20(1), e0317895. https://doi.org/10.1371/journal.pone.0317895

Vancouver

Lip GYH, Benamouzig R, Martin AC, Pesce G, Gusto G, Quignot N, et al. Comparative safety and effectiveness of oral anticoagulants in key subgroups of patients with non-valvular atrial fibrillation and at high risk of gastrointestinal bleeding: A cohort study based on the French National Health Data System (SNDS). PLOS ONE. 2025;20(1):e0317895. doi:10.1371/journal.pone.0317895

BibTeX
@article{Lip2025,
  author = {Lip, Gregory Y H and Benamouzig, Robert and Martin, Anne-Céline and Pesce, Giancarlo and Gusto, Gaelle and Quignot, Nadia and Khachatryan, Artak and Dai, Feng and Sedjelmaci, Fouad and Chaves, Jose and Subash, Rupesh and Mokgokong, Ruth},
  title = {Comparative safety and effectiveness of oral anticoagulants in key subgroups of patients with non-valvular atrial fibrillation and at high risk of gastrointestinal bleeding: A cohort study based on the French National Health Data System (SNDS)},
  journal = {PLOS ONE},
  year = {2025},
  volume = {20},
  number = {1},
  pages = {e0317895},
  doi = {10.1371/journal.pone.0317895}
}
Kostenlos starten →